Randomized Comparative Study of the Effects of Treatment with Once-Daily, Niacin Extended-Release/Lovastatin and with Simvastatin on Lipid Profile and Fibrinolytic Parameters in Taiwan
Hyperlipidemia can be effectively treated either with niacin or HMG-CoA reductase inhibitor (statin), or a combination of both. Few reports showed the effects of the combination regimen with niacin and statin on hemostatic functions. We conducted a single-center, double-blind, double-dummy, randomiz...
Main Authors: | Tsung-Hsien Lin, Wen-Chol Voon, Hsueh-Wei Yen, Chih-Hsin Huang, Ho-Ming Su, Wen-Ter Lai, Sheng-Hsiung Sheu |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2006-06-01
|
Series: | Kaohsiung Journal of Medical Sciences |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S1607551X09703092 |
Similar Items
-
Combinação de fármacos na abordagem das dislipidemias: associação entre estatinas e niacina Combination of drugs: statins and niacin
by: Jairo Lins Borges
Published: (2005-10-01) -
Lercanidipine and Losartan Effects on Blood Pressure and Fibrinolytic Parameters
by: Tsung-Hsien Lin, et al.
Published: (2006-04-01) -
A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01) -
Genetic Variants Associated With Plasma Lipids Are Associated With the Lipid Response to Niacin
by: Sony Tuteja, et al.
Published: (2018-10-01) -
Ca(2+)-dependent regulation of fibrinolytic system activation on fibrin(ogen) D-domains
by: T. A. Yatsenko, et al.
Published: (2017-10-01)